BofA/Merrill Lynch initiates coverage on Questcor Pharmaceuticals (NASDAQ: QCOR) with a Buy. PT $60.00.Shares of Questcor Pharmaceuticals closed at $45.48 yesterday, with a 52 week range of $24.14-$58.91.
Baird upgraded Range Resources (NYSE: RRC) from Neutral to Outperform with a price target of $72.00.Shares of Range Resources closed at $57.50 yesterday, with a 52 week range of $51.56-$77.24.
BofA/Merrill Lynch downgraded Saks Inc. (NYSE: SKS) from Neutral to Underperform.Shares of Saks Inc. closed at $10.89 yesterday, with a 52 week range of $7.67-$12.14.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/